UiPath
AI-powered automation for every enterprise
About UiPath
UiPath is the world's leading robotic process automation (RPA) company, enabling enterprises to automate repetitive, rule-based tasks using software robots. The company has evolved beyond traditional RPA by integrating AI capabilities including document understanding, computer vision, and generative AI into its automation platform.
UiPath's platform allows organizations to discover automation opportunities using process mining, build automations with a visual designer, and deploy software robots that interact with any application — from legacy mainframes to modern web apps. The addition of AI skills like intelligent document processing and natural language understanding has expanded the range of processes that can be automated.
The company serves over 10,000 customers globally, including many of the world's largest enterprises. UiPath's Autopilot feature brings generative AI to automation building, allowing users to describe desired automations in natural language and have the platform generate the workflow, dramatically lowering the barrier to enterprise automation.
Products & Services
UiPath Platform
End-to-end automation platform for building, deploying, and managing software robots
UiPath Autopilot
Generative AI assistant for creating automations from natural language descriptions
Document Understanding
AI-powered extraction of data from unstructured documents, forms, and invoices
Process Mining
AI-driven analysis to discover and prioritize automation opportunities
Leadership
Notable Achievements
- ✓ 10,000+ enterprise customers globally
- ✓ Pioneer and leader in RPA market
- ✓ Autopilot generative AI for automation creation
- ✓ $1.3B+ annual recurring revenue
Competitive Landscape
Companies competing in the same space as UiPath.
NexChron Coverage
Latest articles mentioning UiPath
Pathos AI Raises $237M Series E at $3B Valuation for Cancer Drug Discovery Platform
Pathos AI raised $237 million in Series E funding at a $3 billion valuation, using AI to match cancer patients to clinical trials and identify drug response patterns — one of the largest health AI raises of 2026.
India's Qubo Bets on Standalone AI Devices — Not Hubs — as the Path for Smart Homes in Emerging Markets
Hero Group's Qubo argues India's smart home market needs AI embedded in individual devices at accessible price points, not expensive hubs — a direct challenge to Apple and Google's Western model.
World Bank Flagship AI Report Launched in India, Maps Path for Developing Economies
The World Bank released the World Development Report 2026 in New Delhi, its most authoritative analysis of AI's macro-developmental opportunities and labor disruption risks for low- and middle-income countries.
Toyota Maps Path to 400,000 Robots and $6.4B Annual Spend Across Global Factory Network by 2028
Toyota has mapped one of the most concrete physical AI capital commitments in automotive history: 400,000 robots and roughly $6.4 billion in annual spending, beginning in 2028.
Financial Disclosure: NexChron provides financial data for informational purposes only. This is not investment advice, a recommendation to buy or sell securities, or an offer to transact. Stock prices are delayed up to 15 minutes and sourced from Yahoo Finance. Funding round data is compiled from public reports and may not reflect the most current information. Company valuations, revenue estimates, and financial projections are based on publicly available data and may be inaccurate or outdated. Always consult a qualified financial advisor before making investment decisions. NexChron, its founder, and contributors may hold positions in companies mentioned on this site.